# The Effects of α-adrenergic Receptor Antagonists on Choroid and Pupil

> **NCT03144596** · PHASE4 · COMPLETED · sponsor: **Kocatepe University** · enrollment: 63 (actual)

## Conditions studied

- Benign Prostatic Hyperplasia
- Pupil Anomaly
- Choroid Disease

## Interventions

- **DRUG:** Alfuzosin Hydrochloride 10 MG
- **DRUG:** Tamsulosin Hydrochloride 0.4 MG

## Key facts

- **NCT ID:** NCT03144596
- **Lead sponsor:** Kocatepe University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-29
- **Primary completion:** 2016-02-03
- **Final completion:** 2016-11-19
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2017-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03144596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03144596, "The Effects of α-adrenergic Receptor Antagonists on Choroid and Pupil". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03144596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*